Indivior loses U.S. district court battle, copycat launches imminent

Generic competitors to British drugmaker Indivior Plc's blockbuster opioid addiction treatment are on course to launch sales next week after the firm's attempt to stay a U.S. District court judgement was rejected.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news